Community-acquired pneumonia: Clinical sciences
2,732views

test
00:00 / 00:00
Community-acquired pneumonia: Clinical sciences
Focused chief complaint
Abdominal pain
Altered mental status
Chest pain
Headache
GI bleed: Lower
GI bleed: Upper
Pelvic pain and vaginal bleeding: Pelvic pain
Pelvic pain and vaginal bleeding: Vaginal bleeding
Shortness of breath
Toxic ingestion
Assessments
USMLE® Step 2 questions
0 / 4 complete
Decision-Making Tree
Questions
USMLE® Step 2 style questions USMLE
0 of 4 complete
Transcript
Pneumonia is a lung infection that results in inflammation of one or both lungs. Usually, it is caused by bacteria, like Streptococcus pneumoniae; and viruses, such as influenza, but rarely, pneumonia can be caused by fungi as well.
Now, based on the setting in which pneumonia develops, we can subdivide it into two main types: community-acquired pneumonia, or CAP for short; and hospital-acquired pneumonia, or HAP. When a person develops pneumonia outside of a hospital or within 48 hours after the admission to hospital, it’s considered CAP.
On the other hand, HAP develops after 48 hours of the admission to hospital. Finally, there’s a special subtype of HAP called ventilator-acquired pneumonia, or VAP. VAP refers to pneumonia that occurs in individuals on mechanical ventilation, 48 hours after the endotracheal intubation.
The first thing to do when approaching a patient with suspected CAP is to obtain a focused history and physical examination; send labs, such as ABG, CBC and BMP; monitor pulse oximetry; and get a chest x-ray.
Let’s start with the history. Patients with CAP might report coughing, difficulty breathing, and chest pain during inspiration. Keep in mind that these symptoms develop either outside of the hospital or within 48 hours of admission. They may also have a history of risk factors like COPD, diabetes, smoking, or alcohol use.
Here are some high-yield facts to keep in mind! A productive cough can occur with bacterial infections. However, if the sputum is blood-tinged, consider specific organisms like Streptococcus pneumoniae, Klebsiella pneumoniae, or Legionella pneumophila.
Now, the physical examination often reveals an elevated temperature, tachypnea, and tachycardia. Pay close attention to lung auscultation, which might reveal rales over the affected area. Additionally, if there’s lobar consolidation, the physical exam might demonstrate bronchial breath sounds, egophony, and increased tactile fremitus in the affected lobe.
In contrast, patients with a pleural effusion might present with decreased breath sounds, decreased tactile fremitus, and dullness to chest percussion in the affected area.
Finally, pulse oximetry might reveal a drop in oxygen saturation, while chest X-ray can show new lung infiltrates.
Once you diagnosed CAP based on the history and physical, labs, and imaging studies, the next step is to determine its severity. This is where the pneumonia severity index, or PSI, comes in. PSI categorizes patients into 5 classes based on clinical elements like age and temperature; laboratory elements, such as BUN and glucose; and radiographic elements, like pleural effusion.
Now, let’s talk about low-risk CAP. Classes 1 to 3 are considered low-risk CAP and can be managed at home. The type of treatment is based on whether or not the person has any chronic medical conditions. So, if your patient has no chronic conditions, start them on oral amoxicillin or doxycycline for 5 days. However, if they do have a chronic condition, such as COPD or diabetes mellitus, then make sure to start them on an oral respiratory fluoroquinolone like levofloxacin or moxifloxacin, or a combination of an oral beta-lactam and a macrolide for 5 days.
Okay, let’s switch gears and talk about high-risk CAP. Classes 4 and 5 are considered high-risk CAP and require admission to the hospital. First, use the Infectious Diseases Society of America/ American Thoracic Society CAP criteria, better known as IDSA/ATS CAP criteria, to determine if they should be managed on the hospital floor, or in the ICU. IDSA/ATS CAP criteria include major criteria, such as septic shock or respiratory failure; and minor criteria, like elevated respiratory rate, confusion, uremia, high WBC count, low platelets, hypothermia, multilobar infiltrates, and hypotension.
Now, if your patient has no major or less than 3 minor criteria, admit them to the hospital floor and start them on supplemental oxygen to maintain oxygen saturation above 92%. Additionally, you should look for a causative pathogen, so don’t forget to obtain a blood culture, and a sputum sample for culture and gram stain. You can also test the urine and sputum for pneumococcal antigens. Finally, assess their symptoms daily to check how they are responding to treatment.
If your patient has 1 major or 3 or more minor criteria, admit them to the ICU and start the same treatment as you do for hospital floor patients. Additionally, if the patient presents with respiratory failure, put them on ventilatory support and periodically assess parameters to optimize oxygenation. However, if the patient presents with sepsis, you should also maintain their systolic blood pressure above 90 mmHg using IV fluids and vasopressors.
Sources
- "Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. 200(7):e45-e67." Am J Respir Crit Care Med. (2019)
- "Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia. 40(4):293-300." Scand J Infect Dis. (2008)
- "The Pneumonia Severity Index: A Decade after the Initial Derivation and Validation" Clinical Infectious Diseases (2008)
- "Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia" Chest (2022)
- "Addendum: Cillóniz, C.; Dominedò, C.; Nicolini, A.; Torres, A. PES Pathogens in Severe Community-Acquired Pneumonia. Microorganisms 2019, 7, 49" Microorganisms (2019)
- "Management of pneumonia in critically ill patients" BMJ (2021)
- "Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report" Annals of the American Thoracic Society (2021)
- "Community-acquired pneumonia in the emergency department. 23(2):1-24." Emerg Med Pract. (2021)
- "Nucleic Acid–based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline. 203(9):1070-1087." Am J Respir Crit Care Med. (2021)
- "An Algorithm for the Selection of Probes for Specific Detection of Human Disease Pathogens Using the DNA Microarray Technology" Sovremennye tehnologii v medicine (2022)
- "The SIRS criteria have better performance for predicting infection than qSOFA scores in the emergency department" Scientific Reports (2020)
- "A profile of delafloxacin in the treatment of adults with community-acquired bacterial pneumonia" Expert Review of Clinical Pharmacology (2022)
- "Validation and comparison of three mortality prediction scores in emergency department patients with community-acquired pneumonia." Colombia Medica (2021)
- "A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease" Respiratory Research (2022)
- "Concomitant occurrence of primary renal non-Hodgkin lymphoma and a colon cancer" Medicine (2019)
- "Performance of the CURB-65 Score in Predicting Critical Care Interventions in Patients Admitted With Community-Acquired Pneumonia" Annals of Emergency Medicine (2019)
- "Immunocompetent HA, Emergence OV, COVID A, County MK. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among US Adults: Updated Recommendations of the Advisory Committee on Immunization Practices—United States, 2022." Notes (2022)
- "Comparison between the Severity Scoring Systems A-DROP and CURB-65 for Predicting Safe Discharge from the Emergency Department in Patients with Community-Acquired Pneumonia" Emergency Medicine International (2022)
- "The Berlin definition of acute respiratory distress syndrome: should patients receiving high-flow nasal oxygen be included?" The Lancet Respiratory Medicine (2021)
- "The Use of the SMART-COP Score in Predicting Severity Outcomes Among Patients With Community-Acquired Pneumonia: A Meta-Analysis" Cureus (2022)
- "Community-acquired pneumonia: Strategies for triage and treatment" Cleveland Clinic Journal of Medicine (2020)
- "Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines. 31(3):602-612." Am J Emerg Med. (2013)
- "Updates on community acquired pneumonia management in the ICU" Pharmacology & Therapeutics (2021)
- "The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review" Clinical Microbiology and Infection (2021)
- "Outcome of acute hypoxaemic respiratory failure: insights from the LUNG SAFE Study. 57(6):2002836" Eur Respir J. (2021)
- "Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group" Respiratory Research (2022)
- "Performance of the CORB (Confusion, Oxygenation, Respiratory Rate, and Blood Pressure) Scale for the Prediction of Clinical Outcomes in Pneumonia" Canadian Respiratory Journal (2022)
- "Cost impact analysis of novel host-response diagnostic for patients with community-acquired pneumonia in the emergency department" Journal of Medical Economics (2022)
- "Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR)" Trials (2022)
- "Prediction value of procalcitonin combining CURB-65 for 90-day mortality in community-acquired pneumonia. Expert Rev 15(5):689-696." Respir Med. (2021)
- "qSOFA as a new community-acquired pneumonia severity score in the emergency setting" Emergency Medicine Journal (2020)
- "Predictive factors and outcomes of severe community acquired pneumonia in patients with respiratory failure" Pakistan Journal of Medical Sciences (2022)
- "Diagnostic stewardship aiming at expectorated or induced sputum promotes microbial diagnosis in community-acquired pneumonia" BMC Infectious Diseases (2022)
- "Clinical metagenomics assessments improve diagnosis and outcomes in community-acquired pneumonia" BMC Infectious Diseases (2021)
- "Nomogram for predicting in‐hospital mortality of nonagenarians with community‐acquired pneumonia" Geriatrics & Gerontology International (2022)
- "Community-Acquired Pneumonia: Updated Recommendations from the ATS and IDSA. " Am Fam Physician. (2020;102(2):121-124. )
- "Community-acquired pneumonia. " Lancet (2015;386(9998):1097-108. )